Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Cash & Current Investments (2016 - 2020)

Glucotrack's Cash & Current Investments history spans 7 years, with the latest figure at $10.7 million for Q3 2020.

  • For the quarter ending Q3 2020, Cash & Current Investments rose 775.96% year-over-year to $10.7 million, compared with a TTM value of $10.7 million through Sep 2020, up 775.96%, and an annual FY2019 reading of $419000.0, up 331.61% over the prior year.
  • Cash & Current Investments for Q3 2020 was $10.7 million at Glucotrack, down from $11.5 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $12.4 million in Q1 2020, with the low at $17345.0 in Q2 2018.
  • Average Cash & Current Investments over 5 years is $2.4 million, with a median of $696159.0 recorded in 2016.
  • Year-over-year, Cash & Current Investments plummeted 98.47% in 2018 and then soared 40528.53% in 2020.
  • Tracing GCTK's Cash & Current Investments over 5 years: stood at $148836.0 in 2016, then crashed by 63.86% to $53782.0 in 2017, then surged by 80.5% to $97079.0 in 2018, then soared by 331.61% to $419000.0 in 2019, then skyrocketed by 2455.29% to $10.7 million in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Cash & Current Investments are $10.7 million (Q3 2020), $11.5 million (Q2 2020), and $12.4 million (Q1 2020).